Fractalkine modulates pulmonary angiogenesis and tube formation by modulating CX3CR1 and growth factors in PVECs

This study aimed to investigate effects of pulmonary fractalkine (FKN/CX3CL1) on angiogenesis and tube formation. Tube forming capability of pulmonary vascular endothelial cells (PVECs) was evaluated. CCK-8 assay was used to evaluate proliferation of PVECs. RT-PCR assay was used to determine angioge...

Full description

Bibliographic Details
Main Authors: Liao Jun, Yang Xianwu, Yang Jiejie, Xiao Jingjing, Liu Xuyang, Zhuo Yingquan, Yang Jiafei, Gu Huajian
Format: Article
Language:English
Published: De Gruyter 2023-12-01
Series:Open Life Sciences
Subjects:
Online Access:https://doi.org/10.1515/biol-2022-0670
_version_ 1797349299084853248
author Liao Jun
Yang Xianwu
Yang Jiejie
Xiao Jingjing
Liu Xuyang
Zhuo Yingquan
Yang Jiafei
Gu Huajian
author_facet Liao Jun
Yang Xianwu
Yang Jiejie
Xiao Jingjing
Liu Xuyang
Zhuo Yingquan
Yang Jiafei
Gu Huajian
author_sort Liao Jun
collection DOAJ
description This study aimed to investigate effects of pulmonary fractalkine (FKN/CX3CL1) on angiogenesis and tube formation. Tube forming capability of pulmonary vascular endothelial cells (PVECs) was evaluated. CCK-8 assay was used to evaluate proliferation of PVECs. RT-PCR assay was used to determine angiogenesis specific biomarkers. Western blot was applied to identify CX3CR1, Akt, phosphorylated Akt (p-Akt), Erk1/2, phosphorylated Erk1/2 (p-Erk1/2), vascular endothelial growth factor A (VEGFA), and inducible nitric oxide synthase (iNOS) expression. VEGF-A and platelet-derived growth factor (PDGF) levels were examined using ELISA. FKN was safe and triggered tube formation in PVECs. FKN significantly enhanced VEGF-A, PDGF, and iNOS gene transcription compared to the Control group (p < 0.05). CX3CR1 interfering (LV5-CX3CR1 shRNA) remarkably reduced CX3CR1 expression compared to those in LV5 blank group (p < 0.05). Ratios of p-Akt/Akt and p-Erk/Erk were significantly decreased in CX3CR1 shRNA-treated PVECs administered Akt inhibitor (or Erk inhibitor) and 10 ng/mL FKN compared to CX3CR1 shRNA-treated PVECs administered 10 ng/mL FKN (p < 0.05). FKN increased VEGF-A and iNOS expression through activating Akt/Erk pathway. FKN promoted VEGF-A/iNOS expression and triggered p-Akt/Akt and p-Erk/Erk pathway through modulating CX3CR1. FKN-treated macrophages enhanced activation of Akt/Erk pathway. FKN-treated macrophages enhanced PDGF and VEGF-1 expression in PVECs. FKN modulated pulmonary angiogenesis and tube formation through modulating CX3CR1 and growth factors and activating p-Akt/Akt and p-Erk/Erk signaling pathway.
first_indexed 2024-03-08T12:28:17Z
format Article
id doaj.art-5c383976dc1b4814b7cca9cb7d2d37f7
institution Directory Open Access Journal
issn 2391-5412
language English
last_indexed 2024-03-08T12:28:17Z
publishDate 2023-12-01
publisher De Gruyter
record_format Article
series Open Life Sciences
spelling doaj.art-5c383976dc1b4814b7cca9cb7d2d37f72024-01-22T07:04:04ZengDe GruyterOpen Life Sciences2391-54122023-12-01181e14810.1515/biol-2022-0670Fractalkine modulates pulmonary angiogenesis and tube formation by modulating CX3CR1 and growth factors in PVECsLiao Jun0Yang Xianwu1Yang Jiejie2Xiao Jingjing3Liu Xuyang4Zhuo Yingquan5Yang Jiafei6Gu Huajian7Department of Pediatric Surgery, Affiliated Hospital of Guizhou Medical University, No. 28, Guiyi Street, Yunyan District, Guiyang550002, P. R. ChinaDepartment of Pediatric Surgery, Affiliated Hospital of Guizhou Medical University, No. 28, Guiyi Street, Yunyan District, Guiyang550002, P. R. ChinaDepartment of Hepatobiliary Surgery, Affiliated Hospital of Guizhou Medical University, Guiyang, P. R. ChinaDepartment of Hepatobiliary Surgery, Affiliated Hospital of Guizhou Medical University, Guiyang, P. R. ChinaDepartment of Hepatobiliary Surgery, Affiliated Hospital of Guizhou Medical University, Guiyang, P. R. ChinaDepartment of Pediatric Surgery, Affiliated Hospital of Guizhou Medical University, No. 28, Guiyi Street, Yunyan District, Guiyang550002, P. R. ChinaDepartment of Pediatric Surgery, Affiliated Hospital of Guizhou Medical University, No. 28, Guiyi Street, Yunyan District, Guiyang550002, P. R. ChinaDepartment of Pediatric Surgery, Affiliated Hospital of Guizhou Medical University, No. 28, Guiyi Street, Yunyan District, Guiyang550002, P. R. ChinaThis study aimed to investigate effects of pulmonary fractalkine (FKN/CX3CL1) on angiogenesis and tube formation. Tube forming capability of pulmonary vascular endothelial cells (PVECs) was evaluated. CCK-8 assay was used to evaluate proliferation of PVECs. RT-PCR assay was used to determine angiogenesis specific biomarkers. Western blot was applied to identify CX3CR1, Akt, phosphorylated Akt (p-Akt), Erk1/2, phosphorylated Erk1/2 (p-Erk1/2), vascular endothelial growth factor A (VEGFA), and inducible nitric oxide synthase (iNOS) expression. VEGF-A and platelet-derived growth factor (PDGF) levels were examined using ELISA. FKN was safe and triggered tube formation in PVECs. FKN significantly enhanced VEGF-A, PDGF, and iNOS gene transcription compared to the Control group (p < 0.05). CX3CR1 interfering (LV5-CX3CR1 shRNA) remarkably reduced CX3CR1 expression compared to those in LV5 blank group (p < 0.05). Ratios of p-Akt/Akt and p-Erk/Erk were significantly decreased in CX3CR1 shRNA-treated PVECs administered Akt inhibitor (or Erk inhibitor) and 10 ng/mL FKN compared to CX3CR1 shRNA-treated PVECs administered 10 ng/mL FKN (p < 0.05). FKN increased VEGF-A and iNOS expression through activating Akt/Erk pathway. FKN promoted VEGF-A/iNOS expression and triggered p-Akt/Akt and p-Erk/Erk pathway through modulating CX3CR1. FKN-treated macrophages enhanced activation of Akt/Erk pathway. FKN-treated macrophages enhanced PDGF and VEGF-1 expression in PVECs. FKN modulated pulmonary angiogenesis and tube formation through modulating CX3CR1 and growth factors and activating p-Akt/Akt and p-Erk/Erk signaling pathway.https://doi.org/10.1515/biol-2022-0670fractalkinecx3cr1hepatopulmonary syndrometube formationmacrophages
spellingShingle Liao Jun
Yang Xianwu
Yang Jiejie
Xiao Jingjing
Liu Xuyang
Zhuo Yingquan
Yang Jiafei
Gu Huajian
Fractalkine modulates pulmonary angiogenesis and tube formation by modulating CX3CR1 and growth factors in PVECs
Open Life Sciences
fractalkine
cx3cr1
hepatopulmonary syndrome
tube formation
macrophages
title Fractalkine modulates pulmonary angiogenesis and tube formation by modulating CX3CR1 and growth factors in PVECs
title_full Fractalkine modulates pulmonary angiogenesis and tube formation by modulating CX3CR1 and growth factors in PVECs
title_fullStr Fractalkine modulates pulmonary angiogenesis and tube formation by modulating CX3CR1 and growth factors in PVECs
title_full_unstemmed Fractalkine modulates pulmonary angiogenesis and tube formation by modulating CX3CR1 and growth factors in PVECs
title_short Fractalkine modulates pulmonary angiogenesis and tube formation by modulating CX3CR1 and growth factors in PVECs
title_sort fractalkine modulates pulmonary angiogenesis and tube formation by modulating cx3cr1 and growth factors in pvecs
topic fractalkine
cx3cr1
hepatopulmonary syndrome
tube formation
macrophages
url https://doi.org/10.1515/biol-2022-0670
work_keys_str_mv AT liaojun fractalkinemodulatespulmonaryangiogenesisandtubeformationbymodulatingcx3cr1andgrowthfactorsinpvecs
AT yangxianwu fractalkinemodulatespulmonaryangiogenesisandtubeformationbymodulatingcx3cr1andgrowthfactorsinpvecs
AT yangjiejie fractalkinemodulatespulmonaryangiogenesisandtubeformationbymodulatingcx3cr1andgrowthfactorsinpvecs
AT xiaojingjing fractalkinemodulatespulmonaryangiogenesisandtubeformationbymodulatingcx3cr1andgrowthfactorsinpvecs
AT liuxuyang fractalkinemodulatespulmonaryangiogenesisandtubeformationbymodulatingcx3cr1andgrowthfactorsinpvecs
AT zhuoyingquan fractalkinemodulatespulmonaryangiogenesisandtubeformationbymodulatingcx3cr1andgrowthfactorsinpvecs
AT yangjiafei fractalkinemodulatespulmonaryangiogenesisandtubeformationbymodulatingcx3cr1andgrowthfactorsinpvecs
AT guhuajian fractalkinemodulatespulmonaryangiogenesisandtubeformationbymodulatingcx3cr1andgrowthfactorsinpvecs